Skip to main content

AMD Reports Third Quarter 2025 Financial Results

SANTA CLARA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — AMD (NASDAQ:AMD) today announced financial results for the third quarter of 2025. Third quarter revenue was a record $9.2 billion, gross margin was 52%, operating income was $1.3 billion, net income was $1.2 billion and diluted earnings per share was $0.75. On a non-GAAP(*) basis, gross margin was 54%, operating income was $2.2 billion, net income was $2 billion and diluted earnings per share was $1.20. Our third quarter results did not include any revenue from shipments of AMD Instinct™ MI308 GPU products to China. “We delivered an outstanding quarter, with record revenue and profitability reflecting broad based demand for our high-performance EPYC and Ryzen processors and Instinct AI accelerators,” said Dr. Lisa Su, AMD chair and CEO. “Our record third...

Continue reading

Great Elm Capital Corp. Announces Third Quarter 2025 Financial Results

Company to Host Conference Call and Webcast at 8:30 AM ET on November 5, 2025 Board Maintains $0.37 Per Share Distribution and Announces $10 Million Share Repurchase Authorization GECC Strengthened its Balance Sheet Raising $27 Million of Equity and Refinancing Highest Cost Debt NAV Decline From $12.10 to $10.01 Per Share Primarily Due to Losses on First Brands; NII Lower As Anticipated Due to Uneven CLO JV Distributions and Lack of a Preference Share Dividend  NII Expected to Recover in the Fourth Quarter with Increased CLO JV Distributions, Normalized Interest Expense and Income Generation From New Deployments PALM BEACH GARDENS, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC”) (NASDAQ: GECC), a business development company, today announced its financial results for the third...

Continue reading

Navigator Gas Announces Preliminary Third Quarter 2025 Results (Unaudited)

LONDON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Third Quarter Financial HighlightsOn November 4, 2025, the Board of Directors of Navigator Holdings Ltd., (NYSE: NVGS) (“Navigator Holdings”, “Navigator Gas”, “our”, “we”, “us” or the “Company”) approved a revision to the Company’s existing capital return policy first announced in May 2023 (the “Revised Capital Return Policy”). Under the Revised Capital Return Policy, commencing with the the dividend relating to the third quarter of 2025, the Company intends, subject to operating needs and other circumstances, to pay an increased quarterly cash dividend of $0.07 per share (the “Revised Fixed Element”) and return additional capital in the form of further cash dividends and/or share repurchases, such that the Revised Fixed Element and, if any, the variable...

Continue reading

Fuel Tech Reports 2025 Third Quarter Financial Results

WARRENVILLE, Ill., Nov. 04, 2025 (GLOBE NEWSWIRE) — Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today reported financial results for the third quarter ended September 30, 2025. “We operated profitably in the third quarter, expanded customer relationships for our Air Pollution Control (APC) and FUEL CHEM® business segments, and increased our APC backlog by more than 20% from June 30, 2025,” said Vincent J. Arnone, President and CEO. “We ended the third quarter in a very strong financial position with $33.8 million in cash and investments and no debt. Subsequent to quarter end, we expanded our APC solutions portfolio via a small strategic acquisition of complementary APC intellectual...

Continue reading

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update

Announced intent to separate biopharma operations from substantial royalty assets by YE 2026 Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on track for Nov./Dec. 2025 Phase 2b data for rosnilimab in rheumatoid arthritis featured as late-breaking oral presentation at ACR Convergence 2025 Phase 1b initiated in celiac disease for ANB033, a CD122 antagonist; top-line Phase 1b data anticipated in Q4 2026 GSK announced strong commercial performance for Jemperli, growing >16% quarter-over-quarter to $303 million in Q3 2025 and $785 million YTD 2025 Anaptys anticipates accruing a one-time $75 million commercial sales milestone in Q4 2025 from GSK once Jemperli achieves $1 billion in worldwide net sales >$390 million in annualized Jemperli royalties payable to Anaptys at GSK’s peak sales...

Continue reading

Par Pacific Holdings Reports Third Quarter 2025 Results

HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended September 30, 2025.Net Income of $262.6 million, or $5.16 per diluted share Adjusted Net Income of $302.6 million, or $5.95 per diluted share Adjusted EBITDA of $372.5 million Small refinery exemption (“SRE”) impact of $195.9 million in Adjusted Net Income and $202.6 million in Adjusted EBITDA Repurchased $16.4 million of common stock Closed Hawaii Renewables joint venture in October and received cash proceeds of $100 millionPar Pacific reported net income of $262.6 million, or $5.16 per diluted share, for the quarter ended September 30, 2025, compared to $7.5 million, or $0.13 per diluted share, for the same quarter in 2024. Third quarter 2025 Adjusted...

Continue reading

Macerich Reports Third Quarter 2025 Earnings Results

SANTA MONICA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) has released its Third Quarter 2025 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at investing.macerich.com. As previously announced, management will hold a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today, Tuesday, November 4, 2025, to discuss quarterly results. Participants who wish to join the conference by telephone must register using the dial-in registration link below to receive the dial-in number and a personalized PIN code that will be required to access the call. Participants may join the live webcast by accessing it at the webcast registration link below or in the Investor Relations section of the company’s website at investing.macerich.com. Participant...

Continue reading

THEON announces a new order for Night Vision Goggles worth over €100 million, increasing backlog to c.€700 million

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)4 November 2025 – Theon International Plc (THEON) secured a new order worth over €100 million from a European NATO member state as part of the €300 million framework agreement announced on 17 October. This first tranche of this agreement requires the delivery of several thousands Night Vision Goggles (NVGs), monoculars and binoculars. The deliveries are evenly scheduled for 2026, 2027 and 2028. Additional orders are expected in the short and mid-term under the same agreement, not only for NVGs but also for Thermal clip-ons IRIS-C. In light of recent announcements, year-to-date order intake has exceeded €370 million, with additional new options amounting to €441 million. Consequently, as of 4 November, the soft backlog – excluding orders invoiced in October – stands at...

Continue reading

Publishing of Eimskip’s third quarter 2025 results

Eimskipafélag Íslands hf. will publish its third quarter 2025 results after market closing on Tuesday 11 November.  Investor meeting on 12 November 2025 Eimskip invites investors and market participants to a meeting where Vilhelm Thorsteinsson, CEO and Rósa Guðmundsdóttir, CFO, will present the results. The meeting will be held on Wednesday 12 November at 8:30 GMT at the Company’s headquarters, Sundabakki 2, second floor. The meeting will also be webcasted live in Icelandic on www.eimskip.com/investors. Investors can send questions before the meeting to the email investors@eimskip.com. Documents and a recording of the meeting will be available at the Company’s investor relations website, www.eimskip.is/investors. For further information please contact Guðbjörg Birna Björnsdóttir, Head of Treasury and Investor Relations, tel: +354 844 4752,...

Continue reading

NNIT A/S: On-track performance with doubled profitability

Q3 2025 key highlightsWhile business was still being negatively impacted by macroeconomic and geopolitical uncertainty, there was an uplift in financial performance in the third quarter. Group operating profit excluding special items more than doubled at DKK 35.6m, corresponding to a margin of 8.2% against 3.9% in the third quarter of 2024. The step-change in margin development compared with last quarter and last year was driven by more efficient operations in terms of improving utilization and the effect from cost reducing initiatives carried out during 2024 and the first half of 2025. NNIT continued the momentum from late Q2 into Q3 with a solid order entry, which is a leading indicator into the fourth quarter and full-year 2026. Revenue amounted to DKK 431.6m in Q3 2025, equal to a negative revenue growth of 2.9% and organic growth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.